Industry NewsDrug discovery > Pre-Clinical Development Optibrium Joins Hepatic and Cardiac Toxicity Systems Project and Expands R&D Team
Application NoteCompound Effects on Calcium Transients in Beating Axiogenesis Cor.4U Human iPS Cell-Derived Cardiomyocytes
Application NotePhenotypic Characterization of Toxic Compound Effects on Cardiomyocytes Derived from iPSCs
Industry NewsEurofins Panlabs Strengthens Drug Discovery Services with GE Healthcare’s Cytiva™ Cardiomyocytes
